Falls Church, Virginia. Sep. 22, 2012—A spectrum of disparities exist in the surgical management of…
Older Age Marker May Be More Appropriate for Papillary Thyroid Cancer Prognosis
By ATA | Past News Releases, Thyroid CancerFalls Church, Virginia. Sep. 21, 2012 –Although age 45 is used to establish staging in…
Radioactive Iodine Treatment Should Be Used in Some but Not All Cases of Papillary Thyroid Cancer
By ATA | Past News Releases, Radioactive Iodine, Thyroid CancerFalls Church, Virginia. Sep. 20, 2012 –Radioactive iodine should only be used in the treatment…
Novel Sequencing Tools to Play Important Role in Understanding Form of Papillary Thyroid Cancer
By ATA | Past News Releases, Thyroid CancerFalls Church, Virginia. Sep. 22, 2012 –Next-generation sequencing analyses of the follicular variant of papillary…
American Thyroid Association (ATA) Issues Policy Statement on Minimizing Radiation Exposure from Medical, Dental Diagnostics
By admin | Past News Releases, Thyroid CancerFalls Church, Virginia. June 13, 2012 – The American Thyroid Association today released a policy…
El cáncer de tiroides es el cáncer endocrinológico más frecuente; sin embargo, es raro en comparación con otros cánceres. En los Estados Unidos sólo hay aproximadamente 20,000 pacientes nuevos por año. Aunque el diagnóstico de cáncer suele ser aterrador, el pronóstico para los pacientes con cáncer de tiroides es usualmente excelente.
Thyroid cancer, the most common endocrine-related cancer, presents as a lump (nodule) in the thyroid and usually does not cause any symptoms. Rarely, thyroid
cancer may cause pain, difficulty swallowing, or hoarseness.
Thyroid cancer is rare compared to other cancers. Thyroid cancer is usually very treatable and is often cured with surgery and radioactive iodine
Glitazone Pretreatment Can Boost Efficacy of Radioiodine Therapy in Metastatic Thyroid Cancer
By admin | Past News Releases, Thyroid CancerFalls Church, Virginia. Oct. 28, 2011 – Repeated radio-ablation therapy with iodine-131 to treat metastatic…
Anti-Cancer Drug Linked to Tumor Shrinkage in Patients with Advanced Differentiated Thyroid Cancer
By admin | Past News Releases, Thyroid CancerFalls Church, Virginia. Oct. 27, 2011 – Phase 1 clinical studies of the experimental anticancer…